PBM Leaders
View More
A Conversation with Alan Lotvin, M.D. | Part 3

The president of CVS Caremark discusses specialty pharmacy, competition for the specialty patient and Humira biosimilars hitting the market next year.

A Conversation with Alan Lotvin, M.D. | Part 2

The president of CVS Caremark discusses competition in the PBM industry, new entrants into the business, transparency and the reasons for establishing a group purchasing organization.

A Conversation with Alan Lotvin, M.D. on the PBM Industry’s Reputation | Part 1

The president of CVS Caremark discusses the PBM industry’s reputation, list prices and rebates.

A Conversation with Ken Paulus, Prime Therapeutics President and CEO, Part 4

In this excerpt of an interview with Managed Healthcare Executive®, Paulus discusses the COVID-19 pandemic, Prime's response and the future of its headquarters building.

PBM Leaders: A Conversation with Ken Paulus, Prime Therapeutics President and CEO, Part 3

In the third part of an interview with Managed Healthcare Executive®, Paulus discusses Prime's collaboration with Express Scripts, the GPO they co-own and bringing some uniformity to the pharmacy benefit management of the 23 health plans that Prime services.

PBM Leaders: A Conversation with Ken Paulus, CEO and President of Prime Therapeutics, Part 2

In the second part of an interview with Managing Editor Peter Wehrwein, Paulus talks about the role of PBMs and aligning providers with payers.

PBM Leaders: A Conversation with Ken Paulus, CEO and President of Prime Therapeutics, Part 1

Paulus, a relative newcomer to the industry, discusses the advantages of having a fresh perspective, the complexity of the industry, rebates, and big employers pushing for more transparency.

Official Media Partners

PBMI logo

Join the Community

an mjh life sciences brand

© 2022 MJH Life Sciences and PBMI. All rights reserved.